Uttar Pradesh Teenager Survives Critical Haemophilia Episode After Intensive Noida Treatment
A 19-year-old boy from Uttar Pradesh's Sonbhadra district has successfully overcome a life-threatening medical emergency caused by Haemophilia, a rare inherited blood disorder, following several weeks of intensive treatment at Noida Child PGI.
Critical Condition and Diagnosis
The patient, identified as Master Sumit, was admitted in early December 2025 in critical condition with severe swelling in his legs, internal bleeding, and haemorrhagic shock. Medical professionals later confirmed he was suffering from Haemophilia A, a genetic disorder characterized by the body's deficiency of Factor VIII, a protein essential for proper blood clotting.
In such conditions, even minor injuries can lead to prolonged bleeding or dangerous internal hemorrhages. The disorder affects approximately one in 20,000 children, making early diagnosis particularly challenging in rural and resource-limited areas.
Background and Delayed Diagnosis
Sumit hails from a below-poverty-line family in Auri village, Sonbhadra, and has faced significant hardship. Following his father's death, his mother developed serious mental health issues, leaving Sumit and his siblings to manage household responsibilities through informal work with minimal income.
"Like many children with inherited bleeding disorders in rural India, Sumit's early symptoms went unrecognized," explained a doctor at Noida Child PGI. "Persistent leg pain and swelling during his school years were treated by local practitioners without identifying the underlying cause. Social stigma and lack of awareness further delayed timely medical intervention."
Medical History and Complications
According to medical records, Sumit was first diagnosed in 2023 when he traveled alone to a tertiary care hospital in Delhi with assistance from one of his sisters. He received initial treatment with Factor VIII replacement therapy and continued care through government welfare schemes and a haemophilia support group.
In November 2025, his condition deteriorated significantly. He developed recurrent internal bleeding, including blood in his stools, indicating a lower gastrointestinal hemorrhage. Fear and embarrassment delayed symptom reporting, and on December 2, he was brought to Noida Child PGI in haemorrhagic shock with dangerously low blood pressure and severe blood loss.
Complex Treatment and Recovery
Doctors identified a serious complication: inhibitor-positive haemophilia. "In this condition, the body develops antibodies that neutralize standard clotting factor treatment, making routine therapy ineffective," stated doctors involved in his care. "This presented a major challenge, as conventional Factor VIII was not working."
Sumit required:
- High-dependency care
- Inotropic support
- Oxygen therapy
- Multiple blood transfusions
He was treated with advanced bypassing agents, including recombinant Factor VIIa (rFVIIa), FEIBA, and Emicizumab, provided under government support through the National Health Mission. Multiple medical departments collaborated to control the bleeding.
"From December 13 onwards, Sumit showed steady improvement," the doctor reported. "His bleeding stopped, vital parameters stabilized, and after careful monitoring, he was discharged. Follow-up visits confirmed that he remained stable."
Broader Implications
This case underscores the critical importance of early diagnosis and specialized treatment for rare bleeding disorders, particularly in underserved rural communities. It also highlights the effectiveness of coordinated medical care and government support systems in managing complex health conditions.
